Semaglutide (subQ) Pharmacology Podcast

Semaglutide (subQ) Pharmacology Podcast

Up next

GI Antispasmodics – Test Prep and Practice Pearls

Abdominal cramping and intestinal spasms are common complaints in patients with conditions such as irritable bowel syndrome (IBS). Two of the most frequently prescribed medications for these symptoms are dicyclomine and hyoscyamine. These medications work by blocking muscarinic r ...  Show more

Antacids – Test Prep and Practice Pearls

Heartburn is one of the most common gastrointestinal complaints, and antacids remain a go-to option for fast symptom relief. In this episode, we’ll discuss how common antacids like calcium carbonate, magnesium hydroxide, aluminum hydroxide, and sodium bicarbonate work to neutrali ...  Show more

Recommended Episodes

#326: Ozempic and Other Semaglutide Medications
Straight A Nursing: Study for nursing school exams & NCLEX

Semaglutide, which is sold under the brand names Ozempic, Wegovy and Rybelsus, has become increasingly popular and is a medication you are likely to encounter in the clinical setting and when reviewing your patient’s medical histories. In this article, you’ll learn the key things ...  Show more

#136 How Did Diabetes Medications Become Obesity Meds? Beyond Journal Club on SURMOUNT-1 Trial
Core IM | Internal Medicine Podcast

What is the difference between semaglutide (ozempic) and tirzepatide (mounjaro) in outcomes and mechanism? How did we find out diabetes medications can help with weight loss?Sponsors: Post Investment: Real Estate Syndications || Hellofresh Show Notes & Transcript02:08 Framework f ...  Show more

Semaglutide for Weight Loss
JAMA Clinical Reviews

Semaglutide has recently been shown to induce clinically significant weight loss in patients with obesity that is sustained for as long as the drug is given. Tom Wadden, PhD, from the University of Pennsylvania, discusses results from the series of recent STEP trials and how they ...  Show more

Managing Adverse Effects of Obesity Medications
JAMA Clinical Reviews

New medications for obesity, such as semaglutide and tirzepatide, are highly effective but can be associated with adverse effects that reduce adherence. Obesity expert and author Robert Kushner, MD, joins JAMA Deputy Editor Mary McDermott, MD, to discuss a recent JAMA Insights ar ...  Show more